135 related articles for article (PubMed ID: 9013282)
1. The cholecystokinin receptor antagonist L-364,718 reduces taurocholate-induced pancreatitis in rats.
Kim KH; Lee MG; Kim DG
Int J Pancreatol; 1996 Dec; 20(3):205-11. PubMed ID: 9013282
[TBL] [Abstract][Full Text] [Related]
2. Long-term blockade of cholecystokinin (CCK): effects of L 364,718 (a CCK receptor antagonist) on pancreatic enzyme storage and secretion.
Rodriguez AI; Manso MA; Garcia-Montero AC; Orfao A; de Dios I
Pancreas; 1997 Oct; 15(3):314-22. PubMed ID: 9336798
[TBL] [Abstract][Full Text] [Related]
3. Effects of the specific cholecystokinin antagonist L 364,718 in experimental acute pancreatitis in the rat.
Sjövall S; Ahrén B; Stenram U
Eur Surg Res; 1988; 20(5-6):325-9. PubMed ID: 2465158
[TBL] [Abstract][Full Text] [Related]
4. Total parenteral nutrition affects the tropic effect of cholecystokinin on the exocrine pancreas.
Fan BG; Axelson J; Sternby B; Rehfeld J; Ihse I; Ekelund M
Scand J Gastroenterol; 1997 Apr; 32(4):380-6. PubMed ID: 9140162
[TBL] [Abstract][Full Text] [Related]
5. Role of cholecystokinin in cholestyramine-induced changes of the exocrine pancreas.
Koop I; Lindenthal M; Schade M; Trautmann M; Adler G; Arnold R
Pancreas; 1991 Sep; 6(5):564-70. PubMed ID: 1946314
[TBL] [Abstract][Full Text] [Related]
6. Effect of endogenous cholecystokinin on the course of acute pancreatitis in rats.
Jia D; Yamamoto M; Otsuki M
World J Gastroenterol; 2015 Jul; 21(25):7742-53. PubMed ID: 26167074
[TBL] [Abstract][Full Text] [Related]
7. Effect of FK480, a CCK-A receptor antagonist, on spontaneously developed chronic pancreatitis in WBN/Kob rats.
Ito H; Sogabe H; Kuno M; Satoh Y; Ogawa T; Konishi K; Yoshida K
Pancreas; 1998 Oct; 17(3):295-300. PubMed ID: 9788545
[TBL] [Abstract][Full Text] [Related]
8. Octreotide and cholecystokinin antagonist reduce edema in obstruction-induced acute pancreatitis.
Toriumi Y; Samuel I; Wilcockson DP; Turkelson CM; Solomon TE; Joehl RJ
J Lab Clin Med; 1993 Oct; 122(4):450-4. PubMed ID: 8228560
[TBL] [Abstract][Full Text] [Related]
9. Effect of T-0632, a cholecystokininA receptor antagonist, on experimental acute pancreatitis.
Taniguchi H; Yomota E; Kume E; Shikano T; Endo T; Nagasaki M
Jpn J Pharmacol; 1997 Feb; 73(2):105-12. PubMed ID: 9074944
[TBL] [Abstract][Full Text] [Related]
10. Mediation of trypsin inhibitor-induced pancreatic hypersecretion by secretin and cholecystokinin in rats.
Watanabe S; Takeuchi T; Chey WY
Gastroenterology; 1992 Feb; 102(2):621-8. PubMed ID: 1732130
[TBL] [Abstract][Full Text] [Related]
11. Cholecystokinin antagonist prevents hyperamylasemia and improves pancreatic exocrine function in cerulein-induced acute pancreatitis.
Murayama KM; Drew JB; Nahrwold DL; Joehl RJ
Pancreas; 1990 Jul; 5(4):439-44. PubMed ID: 1696383
[TBL] [Abstract][Full Text] [Related]
12. Asperlicin, a nonpeptidal cholecystokinin receptor antagonist, attenuates sodium taurocholate-induced acute pancreatitis in rats.
Wisner JR; Renner IG
Pancreas; 1988; 3(2):174-9. PubMed ID: 2453874
[TBL] [Abstract][Full Text] [Related]
13. Camostate- and caerulein-induced delay of gastric emptying in the rat: effect of CCK receptor antagonists.
Varga G; Scarpignato C
Eur J Pharmacol; 1996 Jun; 306(1-3):153-9. PubMed ID: 8813627
[TBL] [Abstract][Full Text] [Related]
14. Pancreatic atrophy in rats produced by the cholecystokinin-A receptor antagonist devazepide.
Nylander AG; Chen D; Ihse I; Rehfeld JF; Håkanson R
Scand J Gastroenterol; 1992 Sep; 27(9):743-7. PubMed ID: 1411279
[TBL] [Abstract][Full Text] [Related]
15. The effect of endogenous cholecystokinin released by bombesin and trypsin inhibitor on the regeneration of the pancreas.
Parekh D; Ishizuka J; Townsend CM; Rajaraman S; Thompson JC
Ann Surg; 1993 Dec; 218(6):735-41. PubMed ID: 8257223
[TBL] [Abstract][Full Text] [Related]
16. Effects of loxiglumide on experimental acute pancreatitis in comparison with gabexate mesilate.
Kimura K; Tominaga K; Fujii M; Saito T; Kasai H
Arzneimittelforschung; 1998 Jan; 48(1):65-9. PubMed ID: 9522035
[TBL] [Abstract][Full Text] [Related]
17. Activation of submucosal but not myenteric plexus of the gastrointestinal tract accompanies reduction of food intake by camostat.
Raboin SJ; Reeve JR; Cooper MS; Green GM; Sayegh AI
Regul Pept; 2008 Oct; 150(1-3):73-80. PubMed ID: 18620003
[TBL] [Abstract][Full Text] [Related]
18. The changes in the rat parotid glands following total parenteral nutrition and pancreatico-biliary diversion are not mediated by cholecystokinin.
Axelson J; Fan BG; Ohlsson B; Rehfeld J; Ekelund M; Ihse I
Int J Pancreatol; 1996 Oct; 20(2):109-18. PubMed ID: 8968866
[TBL] [Abstract][Full Text] [Related]
19. The recovery of acute pancreatitis depends on the enzyme amount stored in zymogen granules at early stages.
Manso MA; García-Montero AC; Tabernero MD; Orfao A; De Dios I
Mol Cell Biochem; 1999 Oct; 200(1-2):35-41. PubMed ID: 10569181
[TBL] [Abstract][Full Text] [Related]
20. Changes in both the membrane and the enzyme content of individual zymogen granules are associated with sodium taurocholate-induced pancreatitis in rats.
Manso MA; Orfao A; Tabernero MD; Vicente S; de Dios I
Clin Sci (Lond); 1998 Mar; 94(3):293-301. PubMed ID: 9616264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]